XER-33439-42296
3 vaccinations
8 coded responses
39 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 535 / WI
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
- 2021-01-23
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
- 2021-02-13
-
2021-02-14
Dose 2 — Pfizer-BioNTech
-
2021-02-14
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-16
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-28
- 2021-03-07
-
2021-03-14
Survey response — day 28, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — day 35, dose 2MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Developed cold like symptoms. Extra mucus, stuffy nose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — day 42, dose 2MedDRA: Dysphonia, Nasal congestion, Nasopharyngitis — Feeling: GoodFree text: Stuffy nose, hoarse voice, cold-like symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-16
-
2021-08-15
Survey response — 6 months, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Pain at injection siteMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-02-14
-
2022-04-20
Dose 3 — Pfizer-BioNTech
-
2022-04-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-04-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-04-29
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-07-20
-
2022-10-19
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, Pre-existing disease, Respiratory symptom — Feeling: GoodFree text: Fall allergies, common cold/upper respiratory symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2023-04-20
Survey response — 12 months, dose 3MedDRA: Pharyngitis streptococcal — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-14 | Pfizer-BioNTech | |
| 3 | 2022-04-20 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose
Release 5 — day 28, dose 2
Symptoms: Runny nose
Release 6 — day 35, dose 2
Symptoms: Developed cold like symptoms. Extra mucus, stuffy nose.
Release 6 — day 42, dose 2
Symptoms: Stuffy nose, hoarse voice, cold-like symptoms
Release 9 — 6 months, dose 2
Symptoms: Pain at injection site
Release 12 — 6 months, dose 3
Symptoms: Fall allergies, common cold/upper respiratory symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysphonia | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pharyngitis streptococcal | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release